![(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS](/ep/2020/11/11/EP3736265A1/abs.jpg.150x150.jpg)
基本信息:
- 专利标题: (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- 申请号:EP20165383.9 申请日:2012-10-22
- 公开(公告)号:EP3736265A1 公开(公告)日:2020-11-11
- 发明人: ORTEGA MUÑOZ, Alberto , FYFE, Matthew Colin Thor , MARTINELL PEDEMONTE, Marc , ESTIARTE MARTÍNEZ, María de los Ángeles , VALLS VIDAL, Nuria , KURZ, Guido , CASTRO PALOMINO LARIA, Julio Cesar
- 申请人: Oryzon Genomics, S.A.
- 申请人地址: Carrera de San Jerónimo 15, 2nd Floor 28014 Madrid ES
- 专利权人: Oryzon Genomics, S.A.
- 当前专利权人: Oryzon Genomics, S.A.
- 当前专利权人地址: Carrera de San Jerónimo 15, 2nd Floor 28014 Madrid ES
- 代理机构: Vossius & Partner Patentanwälte Rechtsanwälte mbB
- 优先权: EP11382325 20111020; EP11382331 20111027; US201161558367P 20111110; US201161558365P 20111110
- 主分类号: C07D205/04
- IPC分类号: C07D205/04 ; C07D207/09 ; C07D207/14 ; C07D209/96 ; C07D211/26 ; C07D211/56 ; C07D211/58 ; C07D215/42 ; C07D221/20 ; C07D223/12 ; C07D309/04 ; C07D309/14 ; C07D401/04 ; C07D401/12 ; C07D405/12 ; C07D417/12 ; C07D451/04 ; A61K31/4409 ; A61P35/00
摘要:
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g ., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07D | 杂环化合物 |
------C07D205/00 | 杂环化合物,含四元环、带1个氮原子作为惟一的杂环原子 |
--------C07D205/02 | .不与其他环稠合 |
----------C07D205/04 | ..环原子间或环原子与非环原子间无双键 |